NUVECTIS PHARMA INC

NVCTNASDAQ

🏆 #2594 by market capEarnings Nov 2US Equity

$19.66▲ $0.25 (+1.29%)

Live

1h—

24h▲ 1.3%

7d—

14d—

30d—

1y—

🏦Market Cap

$620M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

50

Weak

Earnings

Q3 · 2026Reported 2026-08-04

Earnings Per Share

Actual

-0.30

Expected

-0.26

miss

−14.50%

YoY +0.00%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q3 2026

-0.30

miss

Q2 2026

-0.26

beat

Q1 2026

-0.31

miss

Q4 2025

-0.44

miss